With more than 72% of taxpayers already opting for the new tax regime, the government is widely expected to further improve its appeal while continuing to keep the old regime available for those who ...

Sitharaman has proposed Biopharma Shakti with an outlay of ₹10,000 crore, which will include a biopharma-focused network featuring three new institutes. In the technology sector, the India ...